Emerging NASH Treatments
Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as:
- Obeticholic acid
- Cenicriviroc
- Resmetirom
- Aramchol
Download the slides from this podcast at:
https://bit.ly/3eJYKvW
See more NASH topics at:
https://bit.ly/3ezkBq6
